20.27 USD
+0.38 (+1.91%)
Taking everything into account, SLP scores 6 out of 10 in our fundamental rating. SLP was compared to 35 industry peers in the Health Care Technology industry. While SLP has a great health rating, its profitability is only average at the moment. SLP is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
- SLP had positive earnings in the past year.
- In the past year SLP had a positive cash flow from operations.
- Of the past 5 years SLP 4 years were profitable.
- Each year in the past 5 years SLP had a positive operating cash flow.
1.2 Ratios
- SLP has a worse Return On Assets (-49.05%) than 71.43% of its industry peers.
- SLP has a Return On Equity of -51.86%. This is comparable to the rest of the industry: SLP outperforms 45.71% of its industry peers.
- The Return On Invested Capital of SLP (4.16%) is better than 71.43% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for SLP is below the industry average of 6.61%.
- The 3 year average ROIC (3.61%) for SLP is below the current ROIC(4.16%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.05% | ||
| ROE | -51.86% | ||
| ROIC | 4.16% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
1.3 Margins
- SLP's Operating Margin of 8.20% is amongst the best of the industry. SLP outperforms 82.86% of its industry peers.
- In the last couple of years the Operating Margin of SLP has declined.
- SLP has a Gross Margin of 58.38%. This is comparable to the rest of the industry: SLP outperforms 51.43% of its industry peers.
- In the last couple of years the Gross Margin of SLP has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.2% | ||
| PM (TTM) | N/A | ||
| GM | 58.38% |
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SLP is destroying value.
- SLP has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, SLP has more shares outstanding
- There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 34.49 indicates that SLP is not in any danger for bankruptcy at the moment.
- The Altman-Z score of SLP (34.49) is better than 100.00% of its industry peers.
- SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 34.49 |
ROIC/WACC0.43
WACC9.65%
2.3 Liquidity
- A Current Ratio of 7.67 indicates that SLP has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 7.67, SLP belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
- A Quick Ratio of 7.67 indicates that SLP has no problem at all paying its short term obligations.
- SLP has a better Quick ratio (7.67) than 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.67 | ||
| Quick Ratio | 7.67 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 50.00% over the past year.
- The Earnings Per Share has been growing slightly by 1.07% on average over the past years.
- The Revenue has grown by 13.09% in the past year. This is quite good.
- SLP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.74% yearly.
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
Revenue 1Y (TTM)13.09%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
3.2 Future
- The Earnings Per Share is expected to grow by 22.12% on average over the next years. This is a very strong growth
- Based on estimates for the next years, SLP will show a quite strong growth in Revenue. The Revenue will grow by 10.39% on average per year.
EPS Next Y32.34%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- SLP is valuated quite expensively with a Price/Earnings ratio of 33.78.
- SLP's Price/Earnings ratio is a bit cheaper when compared to the industry. SLP is cheaper than 71.43% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.33, SLP is valued a bit more expensive.
- Based on the Price/Forward Earnings ratio of 20.83, the valuation of SLP can be described as rather expensive.
- 77.14% of the companies in the same industry are more expensive than SLP, based on the Price/Forward Earnings ratio.
- SLP's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.78 | ||
| Fwd PE | 20.83 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SLP indicates a somewhat cheap valuation: SLP is cheaper than 62.86% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, SLP is valued a bit cheaper than the industry average as 65.71% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.34 | ||
| EV/EBITDA | 24.94 |
4.3 Compensation for Growth
- SLP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.04
PEG (5Y)31.64
EPS Next 2Y29.52%
EPS Next 3Y2.03%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.61%, SLP is not a good candidate for dividend investing.
- SLP's Dividend Yield is rather good when compared to the industry average which is at 0.54. SLP pays more dividend than 94.29% of the companies in the same industry.
- With a Dividend Yield of 0.61, SLP pays less dividend than the S&P500 average, which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
- SLP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
NASDAQ:SLP (1/15/2026, 12:58:58 PM)
20.27
+0.38 (+1.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)01-08 2026-01-08/amc
Earnings (Next)04-01 2026-04-01
Inst Owners79.38%
Inst Owner Change0.01%
Ins Owners17.2%
Ins Owner Change-0.18%
Market Cap408.24M
Revenue(TTM)79.18M
Net Income(TTM)-64.72M
Analysts80
Price Target24.23 (19.54%)
Short Float %6.9%
Short Ratio2.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)180.86%
Min EPS beat(2)40.59%
Max EPS beat(2)321.12%
EPS beat(4)3
Avg EPS beat(4)67.94%
Min EPS beat(4)-90.66%
Max EPS beat(4)321.12%
EPS beat(8)4
Avg EPS beat(8)33%
EPS beat(12)5
Avg EPS beat(12)12.67%
EPS beat(16)8
Avg EPS beat(16)15.11%
Revenue beat(2)2
Avg Revenue beat(2)0.99%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.36%
Revenue beat(4)3
Avg Revenue beat(4)0.73%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)1.36%
Revenue beat(8)6
Avg Revenue beat(8)0.86%
Revenue beat(12)6
Avg Revenue beat(12)-0.85%
Revenue beat(16)10
Avg Revenue beat(16)0.61%
PT rev (1m)0%
PT rev (3m)-9.21%
EPS NQ rev (1m)57.58%
EPS NQ rev (3m)126.09%
EPS NY rev (1m)88.82%
EPS NY rev (3m)82.04%
Revenue NQ rev (1m)-0.78%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)0.39%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.78 | ||
| Fwd PE | 20.83 | ||
| P/S | 5.16 | ||
| P/FCF | 28.34 | ||
| P/OCF | 22.52 | ||
| P/B | 3.27 | ||
| P/tB | 7.87 | ||
| EV/EBITDA | 24.94 |
EPS(TTM)0.6
EY2.96%
EPS(NY)0.97
Fwd EY4.8%
FCF(TTM)0.72
FCFY3.53%
OCF(TTM)0.9
OCFY4.44%
SpS3.93
BVpS6.2
TBVpS2.58
PEG (NY)1.04
PEG (5Y)31.64
Graham Number9.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.05% | ||
| ROE | -51.86% | ||
| ROCE | 5.18% | ||
| ROIC | 4.16% | ||
| ROICexc | 5.61% | ||
| ROICexgc | 26.12% | ||
| OM | 8.2% | ||
| PM (TTM) | N/A | ||
| GM | 58.38% | ||
| FCFM | 18.19% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
ROICexc(3y)6.84%
ROICexc(5y)12.7%
ROICexgc(3y)60.47%
ROICexgc(5y)79.01%
ROCE(3y)4.51%
ROCE(5y)5.69%
ROICexgc growth 3Y-33.77%
ROICexgc growth 5Y-24.05%
ROICexc growth 3Y-37.37%
ROICexc growth 5Y-22.33%
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.34% | ||
| Cap/Sales | 4.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 123.28% | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.67 | ||
| Quick Ratio | 7.67 | ||
| Altman-Z | 34.49 |
F-Score5
WACC9.65%
ROIC/WACC0.43
Cap/Depr(3y)77.49%
Cap/Depr(5y)94.25%
Cap/Sales(3y)6%
Cap/Sales(5y)7.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
EPS Next Y32.34%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue 1Y (TTM)13.09%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
EBIT growth 1Y5.89%
EBIT growth 3Y-24.21%
EBIT growth 5Y-10.96%
EBIT Next Year143.92%
EBIT Next 3Y43.31%
EBIT Next 5Y28.01%
FCF growth 1Y59.7%
FCF growth 3Y1.12%
FCF growth 5Y11.57%
OCF growth 1Y36.08%
OCF growth 3Y0.42%
OCF growth 5Y10.69%
SIMULATIONS PLUS INC / SLP FAQ
What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SLP.
Can you provide the valuation status for SIMULATIONS PLUS INC?
ChartMill assigns a valuation rating of 4 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Fairly Valued.
How profitable is SIMULATIONS PLUS INC (SLP) stock?
SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.
What is the financial health of SIMULATIONS PLUS INC (SLP) stock?
The financial health rating of SIMULATIONS PLUS INC (SLP) is 8 / 10.
Can you provide the expected EPS growth for SLP stock?
The Earnings per Share (EPS) of SIMULATIONS PLUS INC (SLP) is expected to grow by 32.34% in the next year.